GEMZAR 200 mg, poudre pour solution pour perfusion, ACR-368
ACR-368-201
Phase 2 small_molecule active
Quick answer
GEMZAR 200 mg, poudre pour solution pour perfusion, ACR-368 for Endometrial cancer is a Phase 2 program (small_molecule) at Acrivon Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Acrivon Therapeutics
- Indication
- Endometrial cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active